Engineering for new heights in the treatment of Inflammatory Bowel Disease
Spyre Therapeutics is developing potential best-in-class antibodies, rational therapeutic combinations, and precision immunology approaches with the goal of creating Inflammatory Bowel Disease (IBD) therapies with uncompromising efficacy and convenience.
Spyre is on a mission to improve treatment options for IBD. Our team has deep experience developing and commercializing treatments across a broad range of diseases, and is committed to helping patients living with IBD.
We are dedicated to researching potential improvements in efficacy and dosing through our investigational next-generation antibodies and rational combinations. Together with precision immunology approaches, we aspire to provide patients promising new treatment options.